Review began 12/21/2022 review ended 12/27/2022 published 12/31/2022 © copyright

HIGHLIGHTS

• who: Report and collaborators from the Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, USA Orthopedic Surgery, CedarsSinai Medical Center, Los Angeles, USA have published the research: Review began 12/21/2022 Review ended 12/27/2022 Published 12/31/2022 u00a9 Copyright, in the Journal: (JOURNAL) of December/31,/2022
• what: PMH is a rare neoplasm, particularly with the involvement of the bone.

SUMMARY

Pseudomyogenic hemangioendothelioma (PMH) is an endothelial neoplasm, mostly indolent and with lowgrade malignancy, having several different classifications. The current nomenclature was originally described by . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or E-mail:

If you don't have an account, you can create one here.